Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | P2RX7 | Q99572 | 1/20 | 0.32 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fenchone SCHEMBL856607 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (+)-Fenchone SCHEMBL856608 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (L)-Fenchone SCHEMBL18221219 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| Fenchone SCHEMBL15047583 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| (-)-Fenchone SCHEMBL7997210 | 1.00 | MEN1 (0.38) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL19388309 | 0.87 | TSHR (0.35) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL11802436 | 0.86 | MAPT (0.40) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL4140998 | 0.80 | MAPT (0.32) | MAPT | |
| SCHEMBL27818456 | 0.78 | MEN1 (0.35) | MEN1ALDH1A1LMNAMAPTKMT2A | |
| SCHEMBL6623292 | 0.76 | KMT2A (0.41) | MEN1ALDH1A1LMNAMAPTKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 266 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025149901-A1 | AEROSOLISABLE MATERIAL FOR USE IN AN ARTICLE | BT DE Investments Inc. (US) | 2025-07-17 | — | — | WO | claimed |
| WO-2025149903-A1 | AEROSOLISABLE MATERIAL FOR USE IN AN ARTICLE | BT DE Investments Inc. (US) | 2025-07-17 | — | — | WO | claimed |
| EP-4581948-A1 | AEROSOLISABLE MATERIAL FOR USE IN AN ARTICLE | BT DE Investments Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| EP-4581944-A1 | AEROSOLISABLE MATERIAL FOR USE IN AN ARTICLE | BT DE Investments Inc. (US) | 2025-07-09 | — | — | EP | claimed |
| EP-4519404-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | Firmenich SA (CH) | 2025-03-12 | — | — | EP | claimed |
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | THE PROCTER & GAMBLE PLAZA (US) | 2024-03-26 | — | — | US | claimed |
| WO-2023247604-A1 | METHODS FOR ENHANCING MENTAL PERFORMANCE AND COMPOSITIONS FOR USE THEREIN | FIRMENICH SA (CH) | 2023-12-28 | — | — | WO | claimed |
| EP-4216955-A1 | ORAL ANTAGONIST COMPOSITIONS FOR NICOTINE BURNING RELIEF | Fertin Pharma A/S (DK) | 2023-08-02 | — | — | EP | claimed |
| CN-112262227-B | Conformal carbon film deposition | 应用材料公司 | 2022-09-23 | — | — | CN | claimed |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PSOMAGEN, INC. (US) | 2022-08-23 | — | — | US | claimed |
| US-20190050525-A1 | RIESKE-TYPE OXYGENASE/REDUCTASE TARGETED DRUGS FOR DIAGNOSTIC AND TREATMENT OF DISEASES | PSOMAGEN, INC. | 2019-02-14 | — | — | US | claimed |
| WO-2018145219-A1 | PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING ADDICTIONS BY MEANS OF AVERSIVE COUNTERCONDITIONING | SERANI MOSTAZAL JORGE (CL) | 2018-08-16 | — | — | WO | claimed |
| WO-2018053183-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | NOXELL CORPORATION (US) | 2018-03-22 | — | — | WO | claimed |
| WO-2018053065-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | THE PROCTER & GAMBLE COMPANY (US) | 2018-03-22 | — | — | WO | claimed |
| EP-3295925-A1 | COMPOSITION FOR THE PERMANENT DEFORMATION OF HAIR HAVING REDUCED ODOUR | Noxell Corporation (US) | 2018-03-21 | — | — | EP | claimed |
| WO-2018048933-A1 | HAIR COLORING OR BLEACHING COMPOSITION WITH REDUCED ODOR | NOXELL CORPORATION (US) | 2018-03-15 | — | — | WO | claimed |
| EP-3290085-A1 | HAIR COLOURING OR BLEACHING COMPOSITION WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | claimed |
| EP-3290086-A1 | GEL NETWORK HAIR TREATMENT COMPOSITIONS WITH REDUCED ODOUR | Noxell Corporation (US) | 2018-03-07 | — | — | EP | claimed |
| US-20080107573-A1 | METHOD FOR FORMING AN ULTRA LOW DIELECTRIC FILM BY FORMING AN ORGANOSILICON MATRIX AND LARGE POROGENS AS A TEMPLATE FOR INCREASED POROSITY | APPLIED MATERIALS, INC. (US) | 2008-05-08 | — | — | US | claimed |
| US-20050227502-A1 | Method for forming an ultra low dielectric film by forming an organosilicon matrix and large porogens as a template for increased porosity | APPLIED MATERIALS, INC. (US) | 2005-10-13 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11938242-B2 | Apparatus and method for reducing malodor on surfaces | AOX1, AOC2, AOC1 | MEN1 3995/4885ALDH1A1 92/4885LMNA 3720/4885 |
| US-11424006-B2 | Targeted drugs associated with trimethylamine and/or trimeihylamine-n-oxide | PNMT, MAOA, HNMT | MEN1 1637/4885ALDH1A1 988/4885LMNA 2593/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.